2010
DOI: 10.1007/s10620-010-1474-0
|View full text |Cite
|
Sign up to set email alerts
|

Mutational Analysis of the PTEN Gene and Its Effects in Esophageal Squamous Cell Carcinoma

Abstract: The findings of the present study demonstrate that there are mutations in the PTEN gene of the ESCC cells and that the wild type PTEN gene has important effects on the ESCC cells in vitro and in vivo.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 30 publications
(37 reference statements)
0
12
0
Order By: Relevance
“…PTEN can act as a tumor suppressor gene, and some studies have shown that deletion of chromosome 10q results in PTEN gene mutations in some tumors, thereby eliminating gene expression (Ohgaki and Kleihues, 2007;Suvasini et al, 2011). One study determined that PTEN gene expression was decreased in esophageal cancer tissues, and that the level of PTEN protein expression was negatively correlated with tumor size, lymph node metastasis, and the staging of esophageal cancer (Hou et al, 2011). The study found that the carcinogenicity of mir-21 was independent of low PTEN gene expression.…”
Section: Discussionmentioning
confidence: 99%
“…PTEN can act as a tumor suppressor gene, and some studies have shown that deletion of chromosome 10q results in PTEN gene mutations in some tumors, thereby eliminating gene expression (Ohgaki and Kleihues, 2007;Suvasini et al, 2011). One study determined that PTEN gene expression was decreased in esophageal cancer tissues, and that the level of PTEN protein expression was negatively correlated with tumor size, lymph node metastasis, and the staging of esophageal cancer (Hou et al, 2011). The study found that the carcinogenicity of mir-21 was independent of low PTEN gene expression.…”
Section: Discussionmentioning
confidence: 99%
“…Accumulating evidence indicates that numerous molecular changes are associated with EC tumorigenesis, including epidermal growth factor receptor (EGFR) amplification, phosphoinositide 3-kinase, catalytic subunit alpha (PIK3CA) amplification and mutation (8)(9)(10), and phosphatase and tensin homolog (PTEN) mutation or loss (11,12). Alteration of these molecular events contributes to downstream pathway activation (8)(9)(10)(11)(12).…”
Section: Introductionmentioning
confidence: 99%
“…Alteration of these molecular events contributes to downstream pathway activation (8)(9)(10)(11)(12). The phosphoinositide 3-kinase (PI3K)/AKT and mitogen-activated protein kinase kinase (MEK)/ERK signaling pathways are two important pathways that can be activated by EGFR amplification and PTEN loss, which may ultimately lead to tumorigenesis (13).…”
Section: Introductionmentioning
confidence: 99%
“…3), which indicated that PTEN had no activity in these cell lines. On the other hand, PTEN protein had high expression in EC9706-pcDNA3.1-wPTEN cells we screened and kept previously, 9 but it had no obvious expression in EC9706 and EC9706-pcDNA3.1 cells (Fig. 4) (P < 0.001), which indicated that EC9706-pcDNA3.1-wPTEN cells could still express PTEN stably.…”
Section: Expression Of Pten and P-pten In Escc Cells And Ec9706 Cellsmentioning
confidence: 93%
“…PTEN can inhibit the activation of Akt, which implicates in cell proliferation and resistance to apoptosis. 5 But PTEN often loses activity because its mutation, phosphorylation, or hyper-methylation in many human cancers, including ESCC, [6][7][8][9][10] and accordingly results in activating of Akt and mTOR. Rapamycin (rapa), and its analogs can inhibit the activity of mTOR by binding with mTOR and interfere the interaction of mTOR with other target proteins in the pathway, and thus targeting mTOR pathway can be a new strategy for the treatment of malignancies.…”
Section: Introductionmentioning
confidence: 99%